Improving the pharmaceutical care for (liver) transplant recipients

Farmacokinetiek en -dynamiek

Part 1: Optimizing ribavirin therapy in transplant recipients with a chronic hepatitis E virus infection by devoloping a NONMEM model for ribavirin. Part 2: Improving immunosuppressive therapy in liver transplant recipients by performing 2 RCT's in which different immunosuppresive strategies will be compared to modify the tacrolimus related toxicity in this population. Part 3: Evaluate the contribution of an outpatient medication service for liver transplant recipients.



Erasmus MC

Midas B. Mulder

Prof. Dr. Herold Metselaar

Dr. B.C.M. de Winter
Dr. S. Darwish Murad